American Century Companies’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,658
| Closed | -$777K | – | 2859 |
|
|
2025
Q1 | $777K | Sell |
6,658
-73
| -1% | -$8.51K | ﹤0.01% | 2343 |
|
|
2024
Q4 | $570K | Buy |
+6,731
| New | +$570K | ﹤0.01% | 2456 |
|
|
2023
Q3 | – | Sell |
-3,893
| Closed | -$280K | – | 2852 |
|
|
2023
Q2 | $280K | Buy |
+3,893
| New | +$280K | ﹤0.01% | 2416 |
|
|
2021
Q3 | – | Sell |
-129,303
| Closed | -$8.72M | – | 2288 |
|
|
2021
Q2 | $8.72M | Buy |
129,303
+492
| +0.4% | +$33.2K | 0.01% | 858 |
|
|
2021
Q1 | $7.29M | Sell |
128,811
-2,572
| -2% | -$146K | 0.01% | 844 |
|
|
2020
Q4 | $10.7M | Buy |
131,383
+14,694
| +13% | +$1.2M | 0.01% | 749 |
|
|
2020
Q3 | $8.31M | Buy |
116,689
+40,349
| +53% | +$2.87M | 0.01% | 744 |
|
|
2020
Q2 | $6.28M | Buy |
+76,340
| New | +$6.28M | 0.01% | 749 |
|